Protalix BioTherapeutics
PLX
#8648
Rank
S$0.10 B
Marketcap
$1.43
Share price
-4.35%
Change (1 day)
-38.70%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -S$17.63 M

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings (TTM) are -S$17.15 M. In 2023 the company made an earning of S$15.31 M an increase over its 2022 earnings that were of -S$15.46 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$17.63 M-215.14%
2023 S$15.31 M-199.05%
2022 -S$15.46 M-40.38%
2021 -S$25.93 M-732.31%
2020 S$4.1 M-130.53%
2019 -S$13.43 M189.85%
2018 -S$4.64 M-95.29%
2017 -S$98.41 M308.12%
2016 -S$24.12 M-32.37%
2015 -S$35.66 M10.11%
2014 -S$32.38 M-7.59%
2013 -S$35.04 M
2011 -S$40.58 M-19.39%
2010 -S$50.34 M20.87%
2009 -S$41.65 M32.26%
2008 -S$31.49 M-5.46%
2007 -S$33.31 M
2004 -S$0.22 M12.35%
2003 -S$0.2 M-11.1%
2002 -S$0.22 M-57.03%
2001 -S$0.51 M1.03%
2000 -S$0.5 M-53.22%
1999 -S$1.07 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.14 B 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.65 B-3,895.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$1.58 B 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.07 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel